Telecom Healthcare Sector

InnovAge Holding

Market Cap: US$552.5m

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.

Mesa Laboratories

Market Cap: US$548.9m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Mind Medicine (MindMed)

Market Cap: US$548.5m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

Talkspace

Market Cap: US$533.7m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

Enhabit

Market Cap: US$531.7m

Provides home health and hospice services in the United States.

SBC Medical Group Holdings

Market Cap: US$531.5m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Arvinas

Market Cap: US$525.5m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Akso Health Group

Market Cap: US$522.5m

Operates a social e-commerce mobile platform in the People’s Republic of China.

Stoke Therapeutics

Market Cap: US$520.9m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Community Health Systems

Market Cap: US$518.9m

Owns, leases, and operates general acute care hospitals in the United States.

Relay Therapeutics

Market Cap: US$514.3m

Operates as a clinical-stage precision medicines company.

Cullinan Therapeutics

Market Cap: US$510.2m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Eton Pharmaceuticals

Market Cap: US$506.6m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Owens & Minor

Market Cap: US$505.7m

Operates as a healthcare solutions company worldwide.

Bicara Therapeutics

Market Cap: US$504.5m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

EyePoint Pharmaceuticals

Market Cap: US$498.2m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Upstream Bio

Market Cap: US$496.5m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Axogen

Market Cap: US$496.0m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

OrthoPediatrics

Market Cap: US$494.4m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Kura Oncology

Market Cap: US$492.6m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Sana Biotechnology

Market Cap: US$489.5m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Definitive Healthcare

Market Cap: US$484.4m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Tyra Biosciences

Market Cap: US$483.9m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Savara

Market Cap: US$480.4m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Auna

Market Cap: US$473.4m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Botanix Pharmaceuticals

Market Cap: AU$725.5m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Zevra Therapeutics

Market Cap: US$467.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Autolus Therapeutics

Market Cap: US$465.7m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Oxford Biomedica

Market Cap: UK£344.5m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Atai Life Sciences

Market Cap: US$462.8m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Castle Biosciences

Market Cap: US$461.1m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

Amylyx Pharmaceuticals

Market Cap: US$459.1m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Faron Pharmaceuticals Oy

Market Cap: UK£340.3m

Operates as a clinical stage drug discovery and development company.

Theravance Biopharma

Market Cap: US$458.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.